Schonfeld Strategic Advisors LLC Blueprint Medicines Corp Transaction History

Schonfeld Strategic Advisors LLC

  • $14.6 Billion
  • Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 3,950 shares of BPMC stock, worth $341,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,950
Holding current value
$341,240
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$85.18 - $108.78 $336,461 - $429,681
3,950 New
3,950 $425,000
Q1 2023

May 15, 2023
BUY
$37.97 - $50.0 $2.64 Million - $3.48 Million
69,629 New
69,629 $3.13 Million
Q3 2022

Nov 14, 2022
BUY
$49.93 - $77.7 $1.32 Million - $2.06 Million
26,484 New
26,484 $1.74 Million
Q4 2021

Feb 14, 2022
SELL
$94.25 - $115.99 $1.87 Million - $2.3 Million
-19,818 Closed
0 $0
Q3 2021

Nov 16, 2021
BUY
$80.98 - $109.47 $1.24 Million - $1.68 Million
15,318 Added 340.4%
19,818 $2.04 Million
Q2 2021

Aug 16, 2021
BUY
$82.78 - $101.0 $372,510 - $454,500
4,500 New
4,500 $395,000
Q1 2021

May 17, 2021
SELL
$90.71 - $108.28 $2.46 Million - $2.94 Million
-27,137 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$92.08 - $124.48 $1.91 Million - $2.58 Million
20,722 Added 323.02%
27,137 $3.04 Million
Q3 2020

Nov 16, 2020
BUY
$66.45 - $92.7 $426,276 - $594,670
6,415 New
6,415 $595,000
Q1 2020

May 15, 2020
SELL
$48.11 - $82.22 $147,890 - $252,744
-3,074 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$66.73 - $82.59 $2.05 Million - $2.54 Million
-30,726 Reduced 90.91%
3,074 $246,000
Q3 2019

Nov 14, 2019
SELL
$72.9 - $101.41 $8 Million - $11.1 Million
-109,700 Reduced 76.45%
33,800 $2.48 Million
Q2 2019

Aug 14, 2019
BUY
$73.54 - $97.8 $1.58 Million - $2.1 Million
21,500 Added 17.62%
143,500 $13.5 Million
Q1 2019

May 15, 2019
BUY
$48.7 - $86.6 $5.94 Million - $10.6 Million
122,000 New
122,000 $9.77 Million
Q1 2018

May 15, 2018
SELL
$73.28 - $102.95 $995,728 - $1.4 Million
-13,588 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$62.91 - $88.32 $854,821 - $1.2 Million
13,588
13,588 $1.02 Million

Others Institutions Holding BPMC

# of Institutions
338
Shares Held
62M
Call Options Held
987K
Put Options Held
578K
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.16B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email